Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients
Abstract
Increasing evidence shows that alterations in gut microbiome (GM) contribute to the development of type 2 diabetes mellitus (T2DM), and fecal microbiota transplantation (FMT) successfully treats various human diseases. However, the benefits of FMT therapy to T2DM patients remain unknown. We enrolled 17 patients with T2DM for nonblinded, one-armed intervention trial of FMT. A total of 20 healthy individuals were recruited as the baseline control. HbA1c% and metabolic parameter change were evaluated in 17 T2DM patients 12 weeks after they received FMT from healthy donors. The GM composition was characterized by 16S rRNA gene amplicon sequencing from fecal samples prior to and 12 weeks after FMT treatment. We found that the GM of T2DM patients was reconstituted by FMT. We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. Closely evaluating the changes in these assays, we found individual variability in response to FMT treatment. Outmore »
- Authors:
-
- Nanjing Medical University (China)
- Nanjing Medical University (China); Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Publication Date:
- Research Org.:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Biological and Environmental Research (BER); Major Research and Development Project of Jiangsu; Jiangsu Youth Medical Talents Project; Nanjing Science Technology Plan Project; Jiangsu Provincial Health and Health Commission
- OSTI Identifier:
- 1896678
- Grant/Contract Number:
- AC02-05CH11231; BE2016800; QNRC2016674; 201715015; ZDB2020034; M2021056
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Frontiers in Cellular and Infection Microbiology
- Additional Journal Information:
- Journal Volume: 12; Journal ID: ISSN 2235-2988
- Publisher:
- Frontiers Research Foundation
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; fecal microbiota transplantation; type 2 diabetes mellitus; therapeutic biomarker; prospective cohort study; gut microbiome
Citation Formats
Ding, Dafa, Yong, Huijuan, You, Na, Lu, Wei, Yang, Xu, Ye, Xiaolong, Wang, Yayun, Cai, Tingting, Zheng, Xiaoling, Chen, Hui, Cui, Bota, Zhang, Faming, Liu, Xingyin, Mao, Jian-Hua, Lu, Yibing, and Chang, Hang. Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients. United States: N. p., 2022.
Web. doi:10.3389/fcimb.2022.820367.
Ding, Dafa, Yong, Huijuan, You, Na, Lu, Wei, Yang, Xu, Ye, Xiaolong, Wang, Yayun, Cai, Tingting, Zheng, Xiaoling, Chen, Hui, Cui, Bota, Zhang, Faming, Liu, Xingyin, Mao, Jian-Hua, Lu, Yibing, & Chang, Hang. Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients. United States. https://doi.org/10.3389/fcimb.2022.820367
Ding, Dafa, Yong, Huijuan, You, Na, Lu, Wei, Yang, Xu, Ye, Xiaolong, Wang, Yayun, Cai, Tingting, Zheng, Xiaoling, Chen, Hui, Cui, Bota, Zhang, Faming, Liu, Xingyin, Mao, Jian-Hua, Lu, Yibing, and Chang, Hang. Fri .
"Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients". United States. https://doi.org/10.3389/fcimb.2022.820367. https://www.osti.gov/servlets/purl/1896678.
@article{osti_1896678,
title = {Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients},
author = {Ding, Dafa and Yong, Huijuan and You, Na and Lu, Wei and Yang, Xu and Ye, Xiaolong and Wang, Yayun and Cai, Tingting and Zheng, Xiaoling and Chen, Hui and Cui, Bota and Zhang, Faming and Liu, Xingyin and Mao, Jian-Hua and Lu, Yibing and Chang, Hang},
abstractNote = {Increasing evidence shows that alterations in gut microbiome (GM) contribute to the development of type 2 diabetes mellitus (T2DM), and fecal microbiota transplantation (FMT) successfully treats various human diseases. However, the benefits of FMT therapy to T2DM patients remain unknown. We enrolled 17 patients with T2DM for nonblinded, one-armed intervention trial of FMT. A total of 20 healthy individuals were recruited as the baseline control. HbA1c% and metabolic parameter change were evaluated in 17 T2DM patients 12 weeks after they received FMT from healthy donors. The GM composition was characterized by 16S rRNA gene amplicon sequencing from fecal samples prior to and 12 weeks after FMT treatment. We found that the GM of T2DM patients was reconstituted by FMT. We observed a statistically significant decrease in HbA1c% (from 7.565 ± 0.148 to 7.190 ± 0.210, p<0.01), blood glucose (from 8.483 ± 0.497 to 7.286 ± 0.454 mmol/L, p<0.01), and uric acid (from 309.4 ± 21.5 to 259.1 ± 15.8 µmol/L, p<0.01) while a significant increase in postprandial C-peptide (from 4.503 ± 0.600 to 5.471 ± 0.728 ng/ml, p<0.01) at 12 weeks after FMT. Closely evaluating the changes in these assays, we found individual variability in response to FMT treatment. Out of 17 T2DM patients, 11 were found to significantly improve T2DM symptoms. The FMT responders have significantly higher levels of the family Rikenellaceae and the genus Anaerotruncus (family Ruminococcaceae) in their pretreated fecal in comparison to nonresponders, which could predict the clinical response with an area under the curve of 0.83. Our findings suggest that certain T2DM patients can potentially benefit from FMT, and the pretreated abundance of Rikenellaceae and Anaerotruncus in the fecal of patients may serve as potential biomarkers for selecting T2DM patients to receive FMT.},
doi = {10.3389/fcimb.2022.820367},
journal = {Frontiers in Cellular and Infection Microbiology},
number = ,
volume = 12,
place = {United States},
year = {Fri Mar 25 00:00:00 EDT 2022},
month = {Fri Mar 25 00:00:00 EDT 2022}
}
Figures / Tables:
Works referenced in this record:
Considering gut microbiota in treatment of type 2 diabetes mellitus
journal, January 2020
- Adeshirlarijaney, Aneseh; Gewirtz, Andrew T.
- Gut Microbes, Vol. 11, Issue 3
Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
journal, January 2020
- Zhang, Ting; Lu, Gaochen; Zhao, Zhe
- Protein & Cell, Vol. 11, Issue 4
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns
journal, January 2014
- Pamer, E. G.
- Mucosal Immunology, Vol. 7, Issue 2
Gut microbiota and diet in patients with different glucose tolerance
journal, January 2016
- Egshatyan, Lilit; Kashtanova, Daria; Popenko, Anna
- Endocrine Connections, Vol. 5, Issue 1
Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
journal, April 2020
- Allegretti, Jessica R.; Kassam, Zain; Mullish, Benjamin H.
- Clinical Gastroenterology and Hepatology, Vol. 18, Issue 4
Microbiota transplantation: concept, methodology and strategy for its modernization
journal, April 2018
- Zhang, Faming; Cui, Bota
- Protein & Cell, Vol. 9, Issue 5
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
journal, March 2018
- Zhao, Liping; Zhang, Feng; Ding, Xiaoying
- Science, Vol. 359, Issue 6380
Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?
journal, May 2014
- Home, Philip; Riddle, Matthew; Cefalu, William T.
- Diabetes Care, Vol. 37, Issue 6
An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila
journal, November 2018
- Cruz-Aguliar, Rebeca M.; Wantia, Nina; Clavel, Thomas
- Digestion, Vol. 100, Issue 2
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
journal, November 2019
- Saeedi, Pouya; Petersohn, Inga; Salpea, Paraskevi
- Diabetes Research and Clinical Practice, Vol. 157
A metagenome-wide association study of gut microbiota in type 2 diabetes
journal, September 2012
- Qin, Junjie; Li, Yingrui; Cai, Zhiming
- Nature, Vol. 490, Issue 7418
EADSG Guidelines: Insulin Therapy in Diabetes
journal, March 2018
- Silver, Bahendeka; Ramaiya, Kaushik; Andrew, Swai Babu
- Diabetes Therapy, Vol. 9, Issue 2
Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
journal, May 2019
- de Groot, Pieter; Scheithauer, Torsten; Bakker, Guido J.
- Gut, Vol. 69, Issue 3
Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets
journal, January 2020
- Wang, Hui; Lu, Yuan; Yan, Yan
- Frontiers in Cellular and Infection Microbiology, Vol. 9
High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway
journal, October 2012
- Kim, Kyung-Ah; Gu, Wan; Lee, In-Ah
- PLoS ONE, Vol. 7, Issue 10
Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain
journal, January 2021
- Rinott, Ehud; Youngster, Ilan; Yaskolka Meir, Anat
- Gastroenterology, Vol. 160, Issue 1
Human gut microbiome: hopes, threats and promises
journal, June 2018
- Cani, Patrice D.
- Gut, Vol. 67, Issue 9
Gut microbiome in gestational diabetes: a cross-sectional study of mothers and offspring 5 years postpartum
journal, December 2017
- Hasan, Sayyid; Aho, Velma; Pereira, Pedro
- Acta Obstetricia et Gynecologica Scandinavica, Vol. 97, Issue 1
Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss
journal, September 2016
- Remely, Marlene; Hippe, Berit; Zanner, Julia
- Endocrine, Metabolic & Immune Disorders - Drug Targets, Vol. 16, Issue 2
Treat-to-Target Insulin Titration Algorithms When Initiating Long or Intermediate Acting Insulin in Type 2 Diabetes
journal, July 2007
- Strange, Poul
- Journal of Diabetes Science and Technology, Vol. 1, Issue 4
The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis
journal, September 2017
- Qazi, Taha; Amaratunga, Thelina; Barnes, Edward L.
- Gut Microbes, Vol. 8, Issue 6
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
journal, August 2018
- Tuttle, Katherine R.; Lakshmanan, Mark C.; Rayner, Brian
- The Lancet Diabetes & Endocrinology, Vol. 6, Issue 8
Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
journal, April 2019
- Ding, Xiao; Li, Qianqian; Li, Pan
- Drug Safety, Vol. 42, Issue 7
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
journal, October 2020
- de Groot, Pieter; Nikolic, Tanja; Pellegrini, Silvia
- Gut, Vol. 70, Issue 1
Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant Mice
journal, October 2011
- Everard, Amandine; Lazarevic, Vladimir; Derrien, Muriel
- Diabetes, Vol. 60, Issue 11
Connections Between the Gut Microbiome and Metabolic Hormones in Early Pregnancy in Overweight and Obese Women
journal, May 2016
- Gomez-Arango, Luisa F.; Barrett, Helen L.; McIntyre, H. David
- Diabetes, Vol. 65, Issue 8
Human gut microbes impact host serum metabolome and insulin sensitivity
journal, July 2016
- Pedersen, Helle Krogh; Gudmundsdottir, Valborg; Nielsen, Henrik Bjørn
- Nature, Vol. 535, Issue 7612
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
journal, October 2018
- Davies, Melanie J.; D’Alessio, David A.; Fradkin, Judith
- Diabetes Care, Vol. 41, Issue 12
Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition
journal, October 2017
- Kootte, Ruud S.; Levin, Evgeni; Salojärvi, Jarkko
- Cell Metabolism, Vol. 26, Issue 4
Identifying Good Responders to Glucose Lowering Therapy in Type 2 Diabetes: Implications for Stratified Medicine
journal, October 2014
- Jones, Angus G.; Shields, Beverley M.; Hyde, Christopher J.
- PLoS ONE, Vol. 9, Issue 10
The Impact of the Gut Microbiota on Human Health: An Integrative View
journal, March 2012
- Clemente, Jose C.; Ursell, Luke K.; Parfrey, Laura Wegener
- Cell, Vol. 148, Issue 6
Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT)
journal, November 2018
- Lee, Patrick; Yacyshyn, Bruce R.; Yacyshyn, Mary B.
- Diabetes, Obesity and Metabolism, Vol. 21, Issue 3
Role of commensal gut bacteria in inflammatory bowel diseases
journal, November 2012
- Loh, Gunnar; Blaut, Michael
- Gut Microbes, Vol. 3, Issue 6
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results
journal, December 2014
- Cui, Bota; Feng, Qiang; Wang, Honggang
- Journal of Gastroenterology and Hepatology, Vol. 30, Issue 1
Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
journal, March 2020
- Yu, Elaine W.; Gao, Liu; Stastka, Petr
- PLOS Medicine, Vol. 17, Issue 3
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting
journal, March 2018
- Simioni, N.; Berra, C.
- Acta Diabetologica, Vol. 55, Issue 6
Role of gut microbiota in type 2 diabetes pathophysiology
journal, January 2020
- Gurung, Manoj; Li, Zhipeng; You, Hannah
- EBioMedicine, Vol. 51
Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals
journal, October 2017
- Sedighi, Mansour; Razavi, Shabnam; Navab-Moghadam, Fatemeh
- Microbial Pathogenesis, Vol. 111
Figures / Tables found in this record: